|
The European Drug Addiction Prevention (EU-Dap) trial project took place
between 2003-2005. Results indicate a positive shift to prevent the use of
alcohol, tobacco and other drugs among European students aged 12-14 years.
Today,
the EU-Dap project continues by offering access to the
study trial information, classroom
resources for teachers and students, a
dissemination guide; for spreading better practices and an evaluation of the
dissemination strategy.
The aims of the EU-Dap project:
To develop a drug use prevention programme for the European school setting
To evaluate the effectiveness of this programme
To encourage the use of effective drug use prevention
programmes in the European Community and to share of better practicesTo decrease
prevalence of smoking, unhealthy drinking and use of other drugs among European
youth.
Schools are important for implementing drug use prevention programmes
because:
Schools can focus on prevention of alcohol, tobacco and other
drug use when students are young in order to foster healthy children and
adolescents.
The school setting offers the most systematic and efficient
way to reach young people.
Schools are in a position to supervise school
policies that when applied fairly and consistently can support students to
abstain from alcohol, tobacco and other drugs.
Phase II of EU-Dap
officially started with a kick-off meeting, held in Turin, Italy
20-21 October 2006. The steering committee discussed strategies to:
Revise the EU-Dap program “Unplugged”.
Introduce the EU-Dap programme to new countries.
Disseminate effective
prevention programmes.
-
Conduct a field study to evaluate the effectiveness of the
dissemination strategies.
Read more about phase II
The phase I countries that will continue to phase II are: Austria,
Belgium, Greece, Italy, Spain and Sweden. Poland and the Czech Republic have
joined the EU-Dap steering committee to implement the programme as new
participating countries.
EU-Dap was granted by the European
Commission within the 2002 and 2005 Public Health Programme for drug prevention
(Grant #SPC 2002376 and Grant #SPC 2005312).
|